DTIL
Precision BioSciences Inc
NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY
$7.28
-3.77% today
Updated 2026-11-16
Market cap
$288.76M
P/E ratio
30.26
P/S ratio
6.41x
EPS (TTM)
$0.25
Dividend yield
—
52W range
$4 – $11
Volume
0.3M
Precision BioSciences Inc (DTIL) Insider transactions
Net insider activity
Net buying (1,528,604 shares)
Buy transactions
18
Sell transactions
0
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-28 | FRANKEL, STANLEY | Director | P | 1,000 | $6.00 | $6000.00 |
| 2026-09-25 | GERMANO, GENO J | Director | P | 2,609 | $6.28 | $16384.52 |
| 2026-09-25 | BROWN, MELINDA | Director | P | 1,135 | $6.27 | $7116.45 |
| 2026-06-03 | PIRE, SHARI LISA | Director | Buy | 20,979 | — | — |
| 2026-06-03 | GERMANO, GENO J | Director | Buy | 20,979 | — | — |
| 2026-06-03 | FRANKEL, STANLEY | Director | Buy | 20,979 | — | — |
| 2026-06-03 | BUEHLER, KEVIN | Director | Buy | 20,979 | — | — |
| 2026-06-03 | BROWN, MELINDA | Director | Buy | 20,979 | — | — |
| 2026-06-01 | SMITH, J. JEFFERSON | Chief Research Officer | Buy | 57,389 | — | — |
| 2026-06-01 | SCIMECA, DARIO | General Counsel and Secretary | Buy | 107,604 | — | — |
| 2026-06-01 | KELLY, JOHN ALEXANDER | Chief Financial Officer | Buy | 193,688 | — | — |
| 2026-06-01 | AMOROSO, MICHAEL | Director, President and CEO | Buy | 573,888 | — | — |
| 2026-05-20 | PIRE, SHARI LISA | Director | M | 21,000 | — | — |
| 2026-05-20 | PIRE, SHARI LISA | Director | M | 21,000 | — | — |
| 2026-05-20 | GERMANO, GENO J | Director | M | 21,000 | — | — |
| 2026-05-20 | GERMANO, GENO J | Director | M | 21,000 | — | — |
| 2026-05-20 | FRANKEL, STANLEY | Director | M | 21,000 | — | — |
| 2026-05-20 | FRANKEL, STANLEY | Director | M | 21,000 | — | — |
| 2026-05-20 | BUEHLER, KEVIN | Director | M | 21,000 | — | — |
| 2026-05-20 | BUEHLER, KEVIN | Director | M | 21,000 | — | — |
| 2026-05-20 | BROWN, MELINDA | Director | M | 21,000 | — | — |
| 2026-05-20 | BROWN, MELINDA | Director | M | 21,000 | — | — |
| 2026-02-18 | SMITH, J. JEFFERSON | Chief Research Officer | S | 4,925 | $3.84 | $18912.00 |
| 2026-02-18 | SCIMECA, DARIO | General Counsel and Secretary | S | 4,925 | $3.84 | $18912.00 |
| 2026-02-18 | KELLY, JOHN ALEXANDER | Chief Financial Officer | S | 8,149 | $3.84 | $31292.16 |
| 2026-02-18 | AMOROSO, MICHAEL | Director, President and CEO | S | 20,559 | $3.84 | $78946.56 |
| 2026-02-17 | SMITH, J. JEFFERSON | Chief Research Officer | M | 16,667 | — | — |
| 2026-02-17 | SMITH, J. JEFFERSON | Chief Research Officer | M | 16,667 | — | — |
| 2026-02-17 | SCIMECA, DARIO | General Counsel and Secretary | M | 16,667 | — | — |
| 2026-02-17 | SCIMECA, DARIO | General Counsel and Secretary | M | 16,667 | — | — |
| 2026-02-17 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 27,584 | — | — |
| 2026-02-17 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 27,584 | — | — |
| 2026-02-17 | AMOROSO, MICHAEL | Director, President and CEO | M | 67,797 | — | — |
| 2026-02-17 | AMOROSO, MICHAEL | Director, President and CEO | M | 67,797 | — | — |
| 2026-01-22 | AMOROSO, MICHAEL | Director, President and CEO | S | 34,799 | $4.17 | $145111.83 |
| 2026-01-21 | SMITH, J. JEFFERSON | Chief Research Officer | M | 16,219 | — | — |
| 2026-01-21 | SMITH, J. JEFFERSON | Chief Research Officer | S | 10,200 | $4.03 | $41106.00 |
| 2026-01-21 | SCIMECA, DARIO | General Counsel and Secretary | S | 8,854 | $4.03 | $35681.62 |
| 2026-01-21 | KELLY, JOHN ALEXANDER | Chief Financial Officer | S | 15,213 | $4.03 | $61308.39 |
| 2026-01-20 | SMITH, J. JEFFERSON | Chief Research Officer | M | 16,219 | — | — |
| 2026-01-20 | SMITH, J. JEFFERSON | Chief Research Officer | M | 10,447 | — | — |
| 2026-01-20 | SMITH, J. JEFFERSON | Chief Research Officer | M | 2,500 | — | — |
| 2026-01-20 | SMITH, J. JEFFERSON | Chief Research Officer | M | 10,447 | — | — |
| 2026-01-20 | SMITH, J. JEFFERSON | Chief Research Officer | M | 2,500 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 14,908 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 8,425 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 1,978 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 14,908 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 8,425 | — | — |
| 2026-01-20 | SCIMECA, DARIO | General Counsel and Secretary | M | 1,978 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 26,575 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 13,900 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 3,888 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 26,575 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 13,900 | — | — |
| 2026-01-20 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 3,888 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 69,421 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 37,069 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 8,888 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 69,421 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 37,069 | — | — |
| 2026-01-20 | AMOROSO, MICHAEL | Director, President and CEO | M | 8,888 | — | — |
| 2025-12-16 | GERMANO, GENO J | Director | P | 3,000 | $4.72 | $14160.00 |
| 2025-12-16 | FRANKEL, STANLEY | Director | P | 2,700 | $4.70 | $12690.00 |
| 2025-12-15 | BROWN, MELINDA | Director | P | 1,381 | $4.97 | $6863.57 |
| 2025-11-03 | SCIMECA, DARIO | General Counsel and Secretary | S | 665 | $6.49 | $4315.85 |
| 2025-11-03 | KELLY, JOHN ALEXANDER | Chief Financial Officer | S | 1,303 | $6.49 | $8456.47 |
| 2025-11-03 | AMOROSO, MICHAEL | Director, President and CEO | M | 9,444 | — | — |
| 2025-11-03 | AMOROSO, MICHAEL | Director, President and CEO | S | 3,409 | $6.49 | $22124.41 |
| 2025-11-02 | SCIMECA, DARIO | General Counsel and Secretary | M | 1,835 | — | — |
| 2025-11-02 | SCIMECA, DARIO | General Counsel and Secretary | M | 1,835 | — | — |
| 2025-11-02 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 3,605 | — | — |
| 2025-11-02 | KELLY, JOHN ALEXANDER | Chief Financial Officer | M | 3,605 | — | — |
| 2025-11-02 | AMOROSO, MICHAEL | Director, President and CEO | M | 9,444 | — | — |
| 2025-09-26 | FRANKEL, STANLEY | Director | P | 2,700 | $4.97 | $13419.00 |
| 2025-09-22 | BROWN, MELINDA | Director | P | 1,400 | $4.89 | $6846.00 |
| 2025-07-03 | KELLY, JOHN ALEXANDER | Chief Financial Officer | S | 14,827 | $4.26 | $63163.02 |
| 2025-06-25 | BUEHLER, KEVIN | Director | P | 5,076 | $4.16 | $21116.16 |
| 2025-06-25 | BROWN, MELINDA | Director | P | 1,682 | $4.14 | $6963.48 |
| 2025-06-03 | PIRE, SHARI LISA | Director | Buy | 21,000 | — | — |
| 2025-06-03 | GERMANO, GENO J | Director | Buy | 21,000 | — | — |
| 2025-06-03 | FRANKEL, STANLEY | Director | Buy | 21,000 | — | — |
| 2025-06-03 | BUEHLER, KEVIN | Director | Buy | 21,000 | — | — |
| 2025-06-03 | BROWN, MELINDA | Director | Buy | 21,000 | — | — |
| 2025-06-02 | SMITH, J. JEFFERSON | Chief Research Officer | Buy | 50,000 | — | — |
| 2025-06-02 | SCIMECA, DARIO | General Counsel and Secretary | Buy | 50,000 | — | — |
| 2025-06-02 | KELLY, JOHN ALEXANDER | Chief Financial Officer | Buy | 82,750 | — | — |
| 2025-06-02 | AMOROSO, MICHAEL | Director, President and CEO | Buy | 203,390 | — | — |
| 2025-05-27 | PIRE, SHARI LISA | Director | M | 9,826 | — | — |
| 2025-05-27 | PIRE, SHARI LISA | Director | M | 9,826 | — | — |
| 2025-05-27 | GERMANO, GENO J | Director | M | 9,826 | — | — |
| 2025-05-27 | GERMANO, GENO J | Director | M | 9,826 | — | — |
| 2025-05-27 | FRANKEL, STANLEY | Director | M | 9,826 | — | — |
| 2025-05-27 | FRANKEL, STANLEY | Director | M | 9,826 | — | — |
| 2025-05-27 | BUEHLER, KEVIN | Director | M | 9,826 | — | — |
| 2025-05-27 | BUEHLER, KEVIN | Director | M | 9,826 | — | — |
| 2025-05-27 | BROWN, MELINDA | Director | M | 9,826 | — | — |
| 2025-05-27 | BROWN, MELINDA | Director | M | 9,826 | — | — |
| 2025-03-26 | BUEHLER, KEVIN | Director | P | 4,523 | $4.67 | $21122.41 |
| 2025-03-26 | BROWN, MELINDA | Director | P | 1,839 | $4.75 | $8735.25 |
Frequently asked questions
Are DTIL insiders buying or selling?
Over the transactions on record, DTIL insiders have been net buyers, with about $0.00 in stock sold across 0 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at DTIL mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.